Mesoblast (MESO) Cost of Revenue: 2014-2023
Historic Cost of Revenue for Mesoblast (MESO) over the last 7 years, with Jun 2023 value amounting to -$19.0 million.
- Mesoblast's Cost of Revenue fell 272.16% to -$19.0 million in Q2 2023 from the same period last year, while for Mar 2023 it was $30.0 million, marking a year-over-year increase of 12.41%. This contributed to the annual value of $5.1 million for FY2025, which is N/A change from last year.
- Mesoblast's Cost of Revenue amounted to -$19.0 million in Q2 2023, which was down 404.29% from $6.2 million recorded in Q1 2023.
- Mesoblast's 5-year Cost of Revenue high stood at $11.9 million for Q3 2020, and its period low was -$19.0 million during Q2 2023.
- Its 3-year average for Cost of Revenue is $4.5 million, with a median of $6.8 million in 2021.
- Its Cost of Revenue has fluctuated over the past 5 years, first spiked by 341.96% in 2020, then plummeted by 272.16% in 2023.
- Over the past 5 years, Mesoblast's Cost of Revenue (Quarterly) stood at $5.1 million in 2019, then climbed by 25.36% to $6.5 million in 2020, then grew by 2.17% to $6.6 million in 2021, then grew by 19.79% to $7.9 million in 2022, then crashed by 272.16% to -$19.0 million in 2023.
- Its Cost of Revenue was -$19.0 million in Q2 2023, compared to $6.2 million in Q1 2023 and $7.9 million in Q4 2022.